Načítá se...
Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer
There is considerable interest and enthusiasm within the clinical gynecologic oncology community regarding the potential for poly (ADP-ribose) polymerase inhibitors to play a critically relevant role in the management of epithelial ovarian cancer and particularly (although not exclusively) in the se...
Uloženo v:
| Vydáno v: | Womens Health (Lond) |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5784554/ https://ncbi.nlm.nih.gov/pubmed/29313444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505717750694 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|